{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:25:23Z","timestamp":1794029123934,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR \/R015910\/1 \\u2013 2270402"],"award-info":[{"award-number":["MR \/R015910\/1 \\u2013 2270402"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.neuropharm.2026.111222","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:16:32Z","timestamp":1791587792000},"page":"111222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-activity relationships of BnOCPA derivatives at native pre- and postsynaptic adenosine A1Rs"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-4414","authenticated-orcid":false,"given":"Circe","family":"la Mache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-6763","authenticated-orcid":false,"given":"Barbara","family":"Preti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4286-9279","authenticated-orcid":false,"given":"Masood Ahmad","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-3172","authenticated-orcid":false,"given":"Bruno G.","family":"Frenguelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-1867","authenticated-orcid":false,"given":"Mark J.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuropharm.2026.111222_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11302-026-10175-1","article-title":"Is adenosine signalling entering the precision medicine era? From receptor pharmacology to patient stratification","volume":"22","author":"Antonioli","year":"2026","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2026.111222_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bcp.2017.03.014","article-title":"Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism","volume":"135","author":"Baltos","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"5515","key":"10.1016\/j.neuropharm.2026.111222_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1058803","article-title":"G protein betagamma subunit-mediated presynaptic inhibition: regulation of exocytotic fusion downstream of Ca2+ entry","volume":"292","author":"Blackmer","year":"2001","journal-title":"Science"},{"issue":"175","key":"10.1016\/j.neuropharm.2026.111222_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/3-540-29784-7_15","article-title":"Regulation of vesicular monoamine and glutamate transporters by vesicle-associated trimeric G proteins: new jobs for long-known signal transduction molecules","author":"Brunk","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2026.111222_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1113\/jphysiol.1996.sp021193","article-title":"G(o)-2 protein mediates the reduction in Ca2+ currents by somatostatin in cultured ovine somatotrophs","volume":"491","author":"Chen","year":"1996","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111222_bib6","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111222_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","article-title":"The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart","volume":"68","author":"Drury","year":"1929","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111222_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1523\/JNEUROSCI.17-02-00607.1997","article-title":"Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus","volume":"17","author":"Dunwiddie","year":"1997","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111222_bib9","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/jm801456g","article-title":"N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice","volume":"52","author":"Franchetti","year":"2009","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111222_bib10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/ejn.12851","article-title":"Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus","volume":"41","author":"Gon\u00e7alves","year":"2015","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111222_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF00585506","article-title":"Adenosine enhances afterhyperpolarization and accommodation in hippocampal pyramidal cells","volume":"402","author":"Haas","year":"1984","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2026.111222_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107904","article-title":"Role of A1 receptor-activated GIRK channels in the suppression of hippocampal seizure activity","volume":"164","author":"Hill","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111222_bib34","article-title":"Species-dependent actions of the Go\u03b1b selective adenosine A1 receptor agonist BnOCPA","author":"Hill","year":"2022","journal-title":"bioRxiv 2022.12.02.518704"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111222_bib13","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1038\/s12276-025-01588-w","article-title":"Direct crosstalk between GPCRs and ion channels via G proteins","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"6339","key":"10.1016\/j.neuropharm.2026.111222_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/353043a0","article-title":"Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents","volume":"353","author":"Kleuss","year":"1991","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111222_bib16","doi-asserted-by":"crossref","first-page":"13712","DOI":"10.3390\/molecules171213712","article-title":"5'-Chloro-5'-deoxy-(\u00b1)-ENBA, a potent and selective adenosine A(1) receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions","volume":"17","author":"Luongo","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2026.111222_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1165261","article-title":"SNAP25 differentially contributes to Gi\/o-coupled receptor function at glutamatergic synapses in the nucleus accumbens","volume":"17","author":"Manz","year":"2023","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111222_bib18","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/cmdc.201700151","article-title":"Neladenoson bialanate hydrochloride: a prodrug of a partial adenosine A1 receptor agonist for the chronic treatment of heart diseases","volume":"12","author":"Meibom","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neuropharm.2026.111222_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuint.2013.10.001","article-title":"Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex","volume":"73","author":"Neale","year":"2014","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111222_bib19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/npp.2013.4","article-title":"Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors","volume":"38","author":"Neale","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111222_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1044-7431(03)00059-9","article-title":"Functional G-protein heterotrimers are associated with vesicles of putative glutamatergic terminals: implications for regulation of transmitter uptake","volume":"23","author":"Pahner","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111222_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107902","article-title":"LSP5-2157 a new inhibitor of vesicular glutamate transporters","volume":"164","author":"Poirel","year":"2020","journal-title":"Neuropharmacology"},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111222_bib23","doi-asserted-by":"crossref","first-page":"14864","DOI":"10.1021\/acs.jmedchem.2c01414","article-title":"Discovery and structure-activity relationship studies of novel adenosine A1 receptor-selective agonists","volume":"65","author":"Preti","year":"2022","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111222_bib24","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1073\/pnas.89.18.8586","article-title":"Adenosine decreases neurotransmitter release at central synapses","volume":"89","author":"Prince","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111222_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243986","article-title":"Activation of neuronal adenosine A1 receptors causes hypothermia through central and peripheral mechanisms","volume":"15","author":"Province","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111222_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0896-6273(92)90244-8","article-title":"Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus","volume":"9","author":"Scanziani","year":"1992","journal-title":"Neuron"},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2026.111222_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(82)90625-2","article-title":"Intracellular analysis of a postsynaptic action of adenosine in the rat hippocampus","volume":"79","author":"Segal","year":"1982","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111222_bib29","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1073\/pnas.1320962111","article-title":"Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist","volume":"111","author":"Valant","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111222_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2016.08.007","article-title":"The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling","volume":"117","author":"Vecchio","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111222_bib33","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1038\/s41467-022-31652-2","article-title":"Selective activation of G\u03b1ob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression","volume":"13","author":"Wall","year":"2022","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111222_bib31","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1523\/JNEUROSCI.0549-05.2005","article-title":"Galphao2 regulates vesicular glutamate transporter activity by changing its chloride dependence","volume":"25","author":"Winter","year":"2005","journal-title":"J. Neurosci."},{"issue":"29","key":"10.1016\/j.neuropharm.2026.111222_bib32","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1074\/jbc.M116.773523","article-title":"G\u03b2\u03b3 directly modulates vesicle fusion by competing with synaptotagmin for binding to neuronal SNARE proteins embedded in membranes","volume":"292","author":"Zurawski","year":"2017","journal-title":"J. Biol. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:54:29Z","timestamp":1794027269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":32,"alternative-id":["S0028390826003977"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111222","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationships of BnOCPA derivatives at native pre- and postsynaptic adenosine A1Rs","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111222"}}